Phase I study of epigenetic modulation with 5-azacytidine and valproic acid in patients with advanced cancers.
Phase I study of epigenetic modulation with 5-azacytidine and valproic acid in patients with advanced cancers. Clin Cancer Res. 2008 Oct 01; 14(19):6296-301.